Skip to content
Massive Bio

Massive Bio Facebook ad: “PD-L1 High NSCLC Trial”

Massive Bio Facebook ad: PD-L1 High NSCLC Trial

Ran for 80 days, from July 18 to October 6, 2026, the last day Crush saw it.

Run by Massive Bio on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)

Make your own version of this ad

Crush makes it, launches it in your own Meta ad account, scales the winners and pauses the losers.

About this ad

Meta Ad Library ID
1451645790326148
Platforms
Facebook, Instagram, Audience Network, Messenger and Threads
Relaunches
0

How we count

Ad text

For metastatic NSCLC with PD-L1 ≥50% and no actionable mutations, a first-line clinical trial is open. Refer appropriate patients today.

massivebio.com

PD-L1 High NSCLC Trial

PD-L1 ≥50% | No actionable mutations | Treatment-naive advanced NSCLC.'

Learn more: massivebio.com(opens in a new tab)

More from Massive Bio

See all Massive Bio ads

More ads from the top 1,000

See the top 1,000 ads